A detailed history of Novo Holdings transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Novo Holdings holds 1,500,000 shares of MIRM stock, worth $63.3 Million. This represents 4.09% of its overall portfolio holdings.

Number of Shares
1,500,000
Previous 1,500,000 -0.0%
Holding current value
$63.3 Million
Previous $51.3 Million 14.07%
% of portfolio
4.09%
Previous 3.66%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$24.63 - $32.85 $4.54 Million - $6.05 Million
-184,193 Reduced 10.94%
1,500,000 $47.4 Million
Q3 2022

Nov 14, 2022

SELL
$19.98 - $29.44 $6.86 Million - $10.1 Million
-343,131 Reduced 16.93%
1,684,193 $35.4 Million
Q2 2022

Aug 15, 2022

SELL
$18.42 - $27.5 $3.18 Million - $4.75 Million
-172,676 Reduced 7.85%
2,027,324 $37.9 Million
Q1 2022

May 16, 2022

SELL
$15.5 - $23.93 $3.8 Million - $5.87 Million
-245,147 Reduced 10.03%
2,200,000 $48.4 Million
Q3 2019

Nov 14, 2019

BUY
$9.16 - $14.77 $22.4 Million - $36.1 Million
2,445,147 New
2,445,147 $24.6 Million

Others Institutions Holding MIRM

About Mirum Pharmaceuticals, Inc.


  • Ticker MIRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,751,700
  • Market Cap $1.55B
  • Description
  • Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...
More about MIRM
Track This Portfolio

Track Novo Holdings Portfolio

Follow Novo Holdings and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

News

Stay updated on Novo Holdings with notifications on news.